Prudential Financial’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.9M | Buy |
219,590
+28,680
| +15% | +$1.2M | 0.01% | 589 |
|
|
2026
Q1 | $6.15M | Buy |
190,910
+42,005
| +28% | +$1.55M | 0.01% | 837 |
|
|
2025
Q4 | $6.27M | Sell |
148,905
-13,398
| -8% | -$540K | 0.01% | 818 |
|
|
2025
Q3 | $5.57M | Buy |
162,303
+125,185
| +337% | +$3.59M | 0.01% | 865 |
|
|
2025
Q2 | $1M | Buy |
37,118
+23,785
| +178% | +$689K | ﹤0.01% | 1663 |
|
|
2025
Q1 | $475K | Sell |
13,333
-108,670
| -89% | -$4.14M | ﹤0.01% | 1860 |
|
|
2024
Q4 | $4.83M | Buy |
122,003
+104,639
| +603% | +$3.96M | 0.01% | 889 |
|
|
2024
Q3 | $591K | Sell |
17,364
-20,564
| -54% | -$579K | ﹤0.01% | 2142 |
|
|
2024
Q2 | $822K | Sell |
37,928
-23,919
| -39% | -$503K | ﹤0.01% | 1948 |
|
|
2024
Q1 | $1.37M | Sell |
61,847
-61,312
| -50% | -$1.5M | ﹤0.01% | 1667 |
|
|
2023
Q4 | $3.39M | Sell |
123,159
-57,035
| -32% | -$1.38M | 0.01% | 1136 |
|
|
2023
Q3 | $4.02M | Sell |
180,194
-127,302
| -41% | -$3.27M | 0.01% | 993 |
|
|
2023
Q2 | $7.83M | Sell |
307,496
-65,262
| -18% | -$1.58M | 0.01% | 735 |
|
|
2023
Q1 | $8.31M | Sell |
372,758
-21,005
| -5% | -$508K | 0.01% | 703 |
|
|
2022
Q4 | $9.34M | Buy |
393,763
+117,630
| +43% | +$2.73M | 0.02% | 652 |
|
|
2022
Q3 | $4.58M | Buy |
276,133
+68,738
| +33% | +$1.55M | 0.01% | 911 |
|
|
2022
Q2 | $4.13M | Buy |
+207,395
| New | +$4.19M | 0.01% | 983 |
|
|
2022
Q1 | – | Sell |
-81,105
| Closed | -$4.26M | – | 2699 |
|
|
2021
Q4 | $4.26M | Buy |
81,105
+27,693
| +52% | +$1.22M | 0.01% | 1111 |
|
|
2021
Q3 | $2.48M | Buy |
53,412
+6,967
| +15% | +$304K | ﹤0.01% | 1343 |
|
|
2021
Q2 | $1.86M | Sell |
46,445
-217,503
| -82% | -$9.3M | ﹤0.01% | 1518 |
|
|
2021
Q1 | $14.2M | Buy |
263,948
+258,845
| +5,072% | +$14.9M | 0.02% | 631 |
|
|
2020
Q4 | $249K | Sell |
5,103
-3,540
| -41% | -$164K | ﹤0.01% | 2299 |
|
|
2020
Q3 | $281K | Buy |
+8,643
| New | +$275K | ﹤0.01% | 2185 |
|
|
2020
Q1 | – | Sell |
-191,663
| Closed | -$5.35M | – | 2445 |
|
|
2019
Q4 | $5.35M | Sell |
191,663
-479,043
| -71% | -$12.4M | 0.01% | 1093 |
|
|
2019
Q3 | $16.1M | Sell |
670,706
-103,893
| -13% | -$2.76M | 0.03% | 626 |
|
|
2019
Q2 | $22.1M | Buy |
774,599
+365,015
| +89% | +$9.12M | 0.03% | 539 |
|
|
2019
Q1 | $10.2M | Buy |
409,584
+300,295
| +275% | +$5.73M | 0.02% | 830 |
|
|
2018
Q4 | $1.38M | Buy |
109,289
+49,719
| +83% | +$588K | ﹤0.01% | 1705 |
|
|
2018
Q3 | $569K | Buy |
+59,570
| New | +$657K | ﹤0.01% | 2020 |
|
Other funds holding VCYT
AIM
Prudential Financial's VCYT Position: Q2 2026 in Review
Prudential Financial increased its Veracyte (VCYT) stake by 15% in Q2 2026, buying an estimated $1.2M and bringing the position to 219,590 shares worth $12.9M. The position accounts for 0.01% of the portfolio, ranked #589.
Prudential Financial first reported a position in VCYT in Q3 2018 and has held it in 29 quarters since. The position peaked at $22.1M in Q2 2019. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Prudential Financial held 219,590 shares of Veracyte worth $12.9M as of Q2 2026.
- Prudential Financial bought 28,680 Veracyte shares in Q2 2026, an estimated $1.2M.
- Veracyte made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #589 holding.
- Prudential Financial first reported a position in Veracyte in Q3 2018 and has held it in 29 quarters since.
- Prudential Financial's Veracyte position peaked at $22.1M in Q2 2019.
- 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.